Osselaer, J.-C., Doyen, C., Chatelain, C., DEBRY, C., Goffaux, M., Messe, N., van Hooydonk, M., Sonet, A., Bosly, A., Lin, J. S., & Corash, L. M. (2007). Impact of pathogen inactivation (INTERCEPT Blood System (TM)) on platelet utilization during three years of routine use. Transfusion, 47(3), 18A-19A. https://doi.org/10.1111/j.1537-2995.2007.01059.x (Original work published 2007)